Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F5TD
|
|||
Drug Name |
PMID27841036-Compound-37
|
|||
Synonyms |
2X-121
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 2 | [1] | |
Company |
EISAI INC. XU, Weizheng DELAHANTY, Greg WEI, Ling ZHANG, Jie
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H15N5O
|
|||
Canonical SMILES |
C1C2=CC=CC=C2CN1CC3=NC4=NNC(=O)C5=C4C(=CC=C5)N3
|
|||
InChI |
1S/C18H15N5O/c24-18-13-6-3-7-14-16(13)17(21-22-18)20-15(19-14)10-23-8-11-4-1-2-5-12(11)9-23/h1-7H,8-10H2,(H,22,24)(H,19,20,21)
|
|||
InChIKey |
JLFSBHQQXIAQEC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1140964-99-3
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase 1 (PARP1) | Target Info | Inhibitor | [2] |
Poly [ADP-ribose] polymerase 2 (PARP2) | Target Info | Inhibitor | [2] | |
Tankyrase-1 (TNKS-1) | Target Info | Inhibitor | [2] | |
Tankyrase-2 (TNKS-2) | Target Info | Inhibitor | [2] | |
KEGG Pathway | Base excision repair | |||
NF-kappa B signaling pathway | ||||
Apoptosis | ||||
Necroptosis | ||||
Panther Pathway | FAS signaling pathway | |||
Pathway Interaction Database | Integrin-linked kinase signaling | |||
Caspase Cascade in Apoptosis | ||||
Notch-mediated HES/HEY network | ||||
Reactome | Dual Incision in GG-NER | |||
WikiPathways | FAS pathway and Stress induction of HSP regulation | |||
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | ||||
Nanoparticle triggered regulated necrosis | ||||
Corticotropin-releasing hormone |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03878849) Investigation of 2X-121 in Patients With Advanced Ovarian Cancer Selected by the 2X-121 DRP (PREDICT 2X-121). U.S. National Institutes of Health. | |||
REF 2 | PARP inhibitors as antitumor agents: a patent update (2013-2015).Expert Opin Ther Pat. 2017 Mar;27(3):363-382. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.